Cardinal health reports first quarter fiscal 2024 results and raises fiscal 2024 outlook

Revenue increased 10% to $54.8 billion gaap 1 operating loss was $14 million and gaap diluted eps was $0.02, driven by a medical segment goodwill impairment non-gaap operating earnings increased 35% to $571 million, driven by significant increases in both pharmaceutical segment profit and medical segment profit; non-gaap diluted eps increased 44% to $1.73 pharmaceutical segment profit grew 18% to $507 million and the medical segment delivered $71 million in segment profit fiscal 2024 non-gaap eps guidance raised to $6.75 to $7.00, from $6.50 to $6.75 dublin, ohio , nov. 3, 2023  /prnewswire/ -- cardinal health (nyse: cah) today reported first quarter fiscal 2024 revenue of $54.8 billion, an increase of 10% from the first quarter of last year. first quarter gaap operating loss was $14 million due to a non-cash, pre-tax goodwill impairment of $581 million related to the medical segment, due to an increase in the discount rate.
CAH Ratings Summary
CAH Quant Ranking